Publications

Found 15 results
Filters: Author is H. Wu  [Clear All Filters]
2016
Q. Chen, Hu, J., Qin, S. S., Liu, C. L., Wu, H., Wang, J. R., Lu, X. M., Wang, J., Chen, G. Q., Liu, Y., Liu, B. Y., Xu, C. S., Liang, S. D., Chen, Q., Hu, J., Qin, S. S., Liu, C. L., Wu, H., Wang, J. R., Lu, X. M., Wang, J., Chen, G. Q., Liu, Y., Liu, B. Y., Xu, C. S., and Liang, S. D., Protective effects of naringin against gp120-induced injury mediated by P2X7 receptors in BV2 microglial cells, vol. 15, p. -, 2016.
Q. Chen, Hu, J., Qin, S. S., Liu, C. L., Wu, H., Wang, J. R., Lu, X. M., Wang, J., Chen, G. Q., Liu, Y., Liu, B. Y., Xu, C. S., Liang, S. D., Chen, Q., Hu, J., Qin, S. S., Liu, C. L., Wu, H., Wang, J. R., Lu, X. M., Wang, J., Chen, G. Q., Liu, Y., Liu, B. Y., Xu, C. S., and Liang, S. D., Protective effects of naringin against gp120-induced injury mediated by P2X7 receptors in BV2 microglial cells, vol. 15, p. -, 2016.
L. Hou, Li, W., Wei, X., Zhou, Y., Zhuo, Y., Wu, H., Shen, B., Hou, L., Li, W., Wei, X., Zhou, Y., Zhuo, Y., Wu, H., and Shen, B., RETRACTION of “Immune memory responses to HBV vaccine 13-18 years after primary vaccination” by L. Hou, W. Li, X. Wei, Y. Zhou, Y. Zhuo, H. Wu, B. Shen. Genet. Mol. Res. 14 (3): 8466-8472 (2015), vol. 15. p. -, 2016.
L. Hou, Li, W., Wei, X., Zhou, Y., Zhuo, Y., Wu, H., Shen, B., Hou, L., Li, W., Wei, X., Zhou, Y., Zhuo, Y., Wu, H., and Shen, B., RETRACTION of “Immune memory responses to HBV vaccine 13-18 years after primary vaccination” by L. Hou, W. Li, X. Wei, Y. Zhou, Y. Zhuo, H. Wu, B. Shen. Genet. Mol. Res. 14 (3): 8466-8472 (2015), vol. 15. p. -, 2016.
2012
H. Wu, Liu, B. - G., Liu, J. - H., Pan, Y. - S., Yuan, L., and Hu, G. - Z., Phenotypic and molecular characterization of CTX-M-14 extended-spectrum β-lactamase and plasmid-mediated ACT-like AmpC β-lactamase produced by Klebsiella pneumoniae isolates from chickens in Henan Province, China, vol. 11, pp. 3357-3364, 2012.
Bauernfeind A, Chong Y and Schweighart S (1989). Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 17: 316-321. http://dx.doi.org/10.1007/BF01650718 PMid:2689349 Bradford PA (2001). Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14: 933-51. http://dx.doi.org/10.1128/CMR.14.4.933-951.2001 PMid:11585791 PMCid:89009 Bradford PA, Urban C, Mariano N, Projan SJ, et al. (1997). Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the foss of an outer membrane protein. Antimicrob. Agents Chemother. 41: 563-569. PMid:9055993 PMCid:163751 Chen Y, Cheng J, Wang Q, Ye Y, et al. (2009). ACT-3, a novel plasmid-encoded class C β-lactamase in a Klebsiella pneumoniae isolate from China. Int. J. Antimicrob. Agents 33: 95-96. http://dx.doi.org/10.1016/j.ijantimicag.2008.06.026 PMid:18789849 Clinical and Laboratory Standards Institute (2008a). Performance Standards for Antimicrobial Susceptibility Testing, 18th Informational Supplement (M100-S16) CLSI. Wayne. Clinical and Laboratory Standards Institute (2008b). Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals Approved Standard. 3rd edn. (M31-A3) CLSI, Wayne. PMid:21581504 PMCid:2967878 Coudron PE, Moland ES and Thomson KS (2000). Occurrence and detection of AmpC β-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center. J. Clin. Microbiol. 38: 1791-1796. PMid:10790101 PMCid:86590 Coudron PE, Hanson ND and Climo MW (2003). Occurrence of extended-spectrum and AmpC β-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC β-lactamases. J. Clin. Microbiol. 41: 772-777. http://dx.doi.org/10.1128/JCM.41.2.772-777.2003 PMid:12574281 PMCid:149714 De Champs C, Sirot D, Chanal C, Bonnet R, et al. (2000). A 1998 survey of extended-spectrum β-lactamases in Enterobacteriaceae in France. The French Study Group. Antimicrob. Agents Chemother. 44: 3177-3179. http://dx.doi.org/10.1128/AAC.44.11.3177-3179.2000 PMid:11036046 PMCid:101626 Doi Y and Paterson DL (2007). Detection of plasmid-mediated class C β-lactamases. Int. J. Infect. Dis. 11: 191-197. http://dx.doi.org/10.1016/j.ijid.2006.07.008 PMid:17339123 Feizabadi MM, Delfani S, Raji N, Majnooni A, et al. (2010). Distribution of blaTEM, blaSHV, blaCTX-M genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran. Microb. Drug Resist. 16: 49-53. http://dx.doi.org/10.1089/mdr.2009.0096 PMid:19961397 Hu GZ, Chen HY, Si HB, Deng LX, et al. (2008). Phenotypic and molecular characterization of TEM-116 extended-spectrum β-lactamase produced by a Shigella flexneri clinical isolate from chickens. FEMS Microbiol. Lett. 279: 162-166. http://dx.doi.org/10.1111/j.1574-6968.2007.01017.x PMid:18093137 Khalaf NG, Eletreby MM and Hanson ND (2009). Characterization of CTX-M ESBLs in Enterobacter cloacae, Escherichia coli and Klebsiella pneumoniae clinical isolates from Cairo, Egypt. BMC Infect. Dis. 9: 84. http://dx.doi.org/10.1186/1471-2334-9-84 PMid:19497111 PMCid:2701952 Ko KS, Yeom JS, Lee MY, Peck KR, et al. (2008). Clonal dissemination of extended-spectrum β-lactamase (ESBL)- producing Klebsiella pneumoniae isolates in a Korean hospital. J. Korean Med. Sci. 23: 53-60. http://dx.doi.org/10.3346/jkms.2008.23.1.53 PMid:18303199 PMCid:2526503 Lartigue MF, Zinsus C, Wenger A, Bille J, et al. (2007) Extended Spectrum β-Lactamases of the CTX-M type now in Switzerland. Antimicrob. Agents Chemother. 51: 2855-2860. http://dx.doi.org/10.1128/AAC.01614-06 PMid:17470647 PMCid:1932552 Lautenbach E, Strom BL, Bilker WB, Patel JB, et al. (2001). Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin. Infect. Dis. 33: 1288-1294. http://dx.doi.org/10.1086/322667 PMid:11565067 Lavigne JP, Bonnet R, Michaux-Charachon S, Jourdan J, et al. (2004). Post-antibiotic and post-β-lactamase inhibitor effects of ceftazidime plus sulbactam on extended-spectrum β-lactamase-producing Gram-negative bacteria. J. Antimicrob. Chemother. 53: 616-619. http://dx.doi.org/10.1093/jac/dkh140 PMid:14985275 Papanicolaou GA, Medeiros AA and Jacoby GA (1990). Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 34: 2200-2209. http://dx.doi.org/10.1128/AAC.34.11.2200 PMid:1963529 PMCid:172023 Paterson DL and Bonomo RA (2005). Extended-spectrum β-lactamases: a clinical update. Clin. Microbiol. Rev. 18: 657-686. http://dx.doi.org/10.1128/CMR.18.4.657-686.2005 PMid:16223952 PMCid:1265908 Paterson DL, Mulazimoglu L, Casellas JM, Ko WC, et al. (2000). Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin. Infect. Dis. 30: 473-478. http://dx.doi.org/10.1086/313719 PMid:10722430 Queenan AM, Foleno B, Gownley C, Wira E, et al. (2004). Effects of inoculum and β-lactamase activity in AmpC- and extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology. J. Clin. Microbiol. 42: 269-275. http://dx.doi.org/10.1128/JCM.42.1.269-275.2004 PMid:14715764 PMCid:321709 Sirot D (1995). Extended-spectrum plasmid-mediated β-lactamases. J. Antimicrob. Chemother. 36 Suppl A: 19-34. Tenover FC, Emery SL, Spiegel CA, Bradford PA, et al. (2009). Identification of plasmid-mediated AmpC β-lactamases in Escherichia coli, Klebsiella spp., and proteus species can potentially improve reporting of cephalosporin susceptibility testing results. J. Clin. Microbiol. 47: 294-299. http://dx.doi.org/10.1128/JCM.01797-08 PMid:19036936 PMCid:2643671 Winokur PL, Canton R, Casellas JM and Legakis N (2001). Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin. Infect. Dis. 32 Suppl 2: S94-103. http://dx.doi.org/10.1086/320182 PMid:11320450 Yuan L, Liu JH, Hu GZ, Pan YS, et al. (2009). Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli isolates from chickens in Henan Province, China. J. Med. Microbiol. 58: 1449-1453. http://dx.doi.org/10.1099/jmm.0.012229-0 PMid:19574412